Fake and counterfeit versions of popular drugs widely used for diabetes and weight loss could have harmful effects on human health, the World Health Organisation (WHO) said on Thursday and has released a warning on the falsified drugs and has urged individuals to check products properly before using.
The WHO press release has issued warning on fake copies of Novo Nordisk's drugs, Ozempic. The WHO's alert addresses three falsified batches of semaglutide that were detected in Brazil and the UK in October 2023, and the United States in December 2023.